Study of Mirogabalin for Central Neuropathic Pain

Clinical trial NCT03901352 · COMPLETED

Trial details

NCT number: NCT03901352
Sponsor: Daiichi Sankyo Co., Ltd.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Central Neuropathic Pain

Start date: 2019-03-12
Primary completion: 2020-12-28
Enrollment: 300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.